CHLD
CHANGE OF OWNER RECEIVED FROM IB
07/03/2025
Back to search
Official data from USPTO
DEBIOPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
07/05/2025
Trademark type
Combined
Nice classes
42
Filing date
04/20/2007
Registration date
07/08/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/19/2018
Last transaction
07/05/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
5
Owner type
98
Owner location
CH
Examiner
LAWRENCE, SUE
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Après-Demain SA
Après-demain Holding SA
Debiopharm International SA
Debiopharm S.A.
Representatives
Duane M. Byers Nixon & Vanderhye, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific researchindustrial research in the field of pharmaceuticals; development of chemical and scientific products and materials and of scientific apparatus in the fields of biologymedicine and pharmaceuticals; licensing of rights stemming from intellectual property obtained for these goodschemical and scientific materials and apparatus
Publications
History of USPTO decisions and trademark events.
37 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/14/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/14/2019
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/19/2018
71AG
REGISTERED-SEC.71 ACCEPTED
07/19/2018
ES71
TEAS SECTION 71 RECEIVED
07/09/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/08/2017
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
01/23/2015
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
01/23/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/23/2015
ES75
TEAS SECTION 71 & 15 RECEIVED
12/28/2014
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/26/2014
RNWL
INTERNATIONAL REGISTRATION RENEWED
04/03/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/30/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/24/2008
FIMP
FINAL DISPOSITION PROCESSED
10/23/2008
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/08/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
07/08/2008
PUBO
PUBLISHED FOR OPPOSITION
04/22/2008
NPUB
NOTICE OF PUBLICATION
04/02/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/17/2008
ALIE
ASSIGNED TO LIE
03/17/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/26/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/05/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/05/2008
DOCK
ASSIGNED TO EXAMINER
11/14/2007
RFNT
REFUSAL PROCESSED BY IB
08/31/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/07/2007
RFRR
REFUSAL PROCESSED BY MPU
08/07/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/07/2007
CNRT
NON-FINAL ACTION WRITTEN
08/06/2007
DOCK
ASSIGNED TO EXAMINER
08/04/2007
NWAP
NEW APPLICATION ENTERED
05/25/2007
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
05/24/2007
Continuous trademark protection
Get notified about every new filing that threatens DEBIOPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.